乌鸦传媒

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 乌鸦传媒, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

A photo of a physicians and a female patient in the cardiac catheterization laboratory.

<乌鸦传媒>Cath Labs Vary Widely in Cardiac Arrest Survival

"Call to action" sounded on study findings

A photo of a mom holding her daughter who is suffering from dystrophic epidermolysis bullosa

<乌鸦传媒>Topical Gene Therapy Heals Blistering Skin Disease Lesions

Randomized trial shows "dramatic" benefits in rare genetic disease

A photo of a teal rubber gloved hand holding a prosthetic aortic valve.

<乌鸦传媒>TAVR at 20: How Much Longer Will Medicare Mandate a Registry?

Change is a-comin' but interventionalists debate just how soon that should be and what comes next

Illustration of a hospital bed, IV, and a red medical plus icon in a circle over a heart with cardiomyopathy

<乌鸦传媒>Inpatient Management of Cardiomyopathy

While tackling congestion is key, the admission is an opportunity to redirect the clinical course

Illustration of a cell phone with a finger pressing a red medical plus icon over a heart with cardiomyopathy

<乌鸦传媒>For Your Cardiomyopathy Patients: Knowing When to Seek Medical Care

Warning signs and signals that you need to seek prompt medical attention

AHA over a computer rendering of the heart.

<乌鸦传媒>Clinical Challenges: Treating Recovered Dilated Cardiomyopathy

Optimal strategies aren't well established, but continuing medications has a clear mandate

A package of Pfizer Paxlovid, a treatment for COVID-19.

<乌鸦传媒>Paxlovid Vindicated for Younger COVID Patients

CDC study supports similar benefit in those under 50 as in seniors

AHA over a computer rendering of the heart.

<乌鸦传媒>Anticoagulation Again Flops for Outpatient COVID-19

Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk

AHA over a computer rendering of the heart.

<乌鸦传媒>Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit

Randomized trial shows advantages across heart failure spectrum

AHA over a computer rendering of the heart.

<乌鸦传媒>Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI

BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin

鈥�

23

鈥�